These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29761663)

  • 41. Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity.
    Fiorentino A; Mazzola R; Ricchetti F; Giaj Levra N; Fersino S; Naccarato S; Sicignano G; Ruggieri R; Di Paola G; Massocco A; Gori S; Alongi F
    Cancer Radiother; 2015 Aug; 19(5):289-94. PubMed ID: 26206732
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term Outcomes of a Dose-reduction Trial to Decrease Late Gastrointestinal Toxicity in Patients with Prostate Cancer Receiving Soft Tissue-matched Image-guided Intensity-modulated Radiotherapy.
    Sasaki N; Yamazaki H; Shimizu D; Suzuki G; Masui K; Nakamura S; Okabe H; Nishikawa T; Yoshida K
    Anticancer Res; 2018 Jan; 38(1):385-391. PubMed ID: 29277799
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Definitive-intent intensity-modulated radiation therapy provides similar outcomes to those previously published for definitive-intent three-dimensional conformal radiation therapy in dogs with primary brain tumors: A multi-institutional retrospective study.
    Van Asselt N; Christensen N; Meier V; Rohrer Bley C; Laliberte S; Poirier VJ; Desai N; Chen Y; Turek M
    Vet Radiol Ultrasound; 2020 Jul; 61(4):481-489. PubMed ID: 32356907
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reducing margins for abdominopelvic tumours in dogs: Impact on dose-coverage and normal tissue complication probability.
    Meier V; Staudinger C; Radonic S; Besserer J; Schneider U; Walsh L; Rohrer Bley C
    Vet Comp Oncol; 2021 Jun; 19(2):266-274. PubMed ID: 33372354
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early clinical outcome of coverage probability based treatment planning for simultaneous integrated boost of nodes in locally advanced cervical cancer.
    Lindegaard JC; Assenholt M; Ramlov A; Fokdal LU; Alber M; Tanderup K
    Acta Oncol; 2017 Nov; 56(11):1479-1486. PubMed ID: 28849684
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dosimetric and radiobiological consequences of computed tomography-guided adaptive strategies for intensity modulated radiation therapy of the prostate.
    Battista JJ; Johnson C; Turnbull D; Kempe J; Bzdusek K; Van Dyk J; Bauman G
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):874-80. PubMed ID: 23978708
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1).
    Ferro M; Chiesa S; Macchia G; Cilla S; Bertini F; Frezza G; Farioli A; Cammelli S; Balducci M; Ianiro A; Angelini AL; Compagnone G; Valentini V; Deodato F; Morganti AG
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):82-90. PubMed ID: 27843034
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term results of a study using individualized planning target volumes for hypofractionated intensity-modulated radiotherapy boost for prostate cancer.
    Chu W; Loblaw DA; Chan K; Morton G; Choo R; Szumacher E; Danjoux C; Pignol JP; Cheung P
    Radiat Oncol; 2015 Apr; 10():95. PubMed ID: 25903934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prospective study of special stage II (T2b-3N0M0) non-small-cell lung cancer treated with hypofractionated-simultaneous integrated boost-intensity modulated radiation therapy.
    Zhang W; Liu C; Lin H; Song Y; Huang W; Li H; Li M; Li B
    J Cancer Res Ther; 2015; 11(2):381-7. PubMed ID: 26148604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicity.
    Hoppe BS; Wolden SL; Zelefsky MJ; Mechalakos JG; Shah JP; Kraus DH; Lee N
    Head Neck; 2008 Jul; 30(7):925-32. PubMed ID: 18302261
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An individualized radiation dose escalation trial in non-small cell lung cancer based on FDG-PET imaging.
    Wanet M; Delor A; Hanin FX; Ghaye B; Van Maanen A; Remouchamps V; Clermont C; Goossens S; Lee JA; Janssens G; Bol A; Geets X
    Strahlenther Onkol; 2017 Oct; 193(10):812-822. PubMed ID: 28733723
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A phase I/II study piloting accelerated partial breast irradiation using CT-guided intensity modulated radiation therapy in the prone position.
    Bergom C; Prior P; Kainz K; Morrow NV; Ahunbay EE; Walker A; Allen Li X; White J
    Radiother Oncol; 2013 Aug; 108(2):215-9. PubMed ID: 23932158
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intensity-modulated radiotherapy as primary therapy for prostate cancer: report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion.
    Fonteyne V; Villeirs G; Speleers B; De Neve W; De Wagter C; Lumen N; De Meerleer G
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):799-807. PubMed ID: 18407430
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcome of a dog undergoing definitive-intent intensity-modulated radiation therapy for an intranasal ganglioneuroma.
    Kitagawa K; Reich SN; Desai N; Policelli R; Zimmerman A; Sledge D; Vilar Saavedra P
    Vet Radiol Ultrasound; 2020 Sep; 61(5):E50-E54. PubMed ID: 32542944
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exposure Risks Among Children Undergoing Radiation Therapy: Considerations in the Era of Image Guided Radiation Therapy.
    Hess CB; Thompson HM; Benedict SH; Seibert JA; Wong K; Vaughan AT; Chen AM
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):978-92. PubMed ID: 27026304
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study.
    Macchia G; Cilla S; Deodato F; Legge F; Di Stefano A; Chiantera V; Scambia G; Valentini V; Morganti AG; Ferrandina G
    Br J Radiol; 2015; 88(1055):20150385. PubMed ID: 26388108
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
    Hein PA; Gladstone DJ; Bellerive MR; Hug EB
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of conventional radiotherapy and intensity-modulated radiotherapy for post-operative radiotherapy for primary extremity soft tissue sarcoma.
    Stewart AJ; Lee YK; Saran FH
    Radiother Oncol; 2009 Oct; 93(1):125-30. PubMed ID: 19604591
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radiation therapy for nasopharyngeal carcinoma using simultaneously integrated boost (SIB) protocol: a comparison planning study between intensity modulated arc radiotherapy vs. intensity modulated radiotherapy.
    Liu T; Chen J; Gong G; Zhang G; Bai T; Sun T; Lu J; Ma C; Yin Y
    Technol Cancer Res Treat; 2012 Oct; 11(5):415-20. PubMed ID: 22568626
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer.
    Al-Mamgani A; Heemsbergen WD; Peeters ST; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):685-91. PubMed ID: 18718725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.